The trajectory of companies tied to flagship drugs like Viagra presents a complex investment landscape . While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the patent expiration in key regions has introduced significant risk . Investors are now grappling with the impact of lower-cost a